Smart Insulin Pen Market by Type, Usability, Application, End-User

Description

List of Tables

[189 Pages Report] The Smart Insulin Pen Market size was estimated at USD 149.62 million in 2023 and expected to reach USD 169.95 million in 2024, at a CAGR 14.14% to reach USD 377.64 million by 2030.

The smart insulin pen, referred to as a digital insulin pen, is a sophisticated medical device intricately designed to aid people with diabetes in accurately administering and monitoring their insulin dosage. Unlike the traditional insulin pens, the smart insulin pen utilizes advanced technology to facilitate effortless diabetes management. The global rise in diabetes cases and awareness about the disease have significantly improved the use of smart insulin pens. Technological advancements and increased investment in research and development activities also enhance the availability of smart insulin pens. However, high costs associated with the pens and technical difficulties may limit the availability and usage of products worldwide. Furthermore, ongoing research into developing pens with prolonged lifespans and multi-day insulin delivery capabilities can provide a substantial opportunity for smart insulin pens market.

KEY MARKET STATISTICS
Base Year [2023]	USD 149.62 million
Estimated Year [2024]	USD 169.95 million
Forecast Year [2030]	USD 377.64 million
CAGR (%)	14.14%

Type: Second-generation pens offer higher control to diabetes management

The first-generation smart insulin pens represent a significant technological leap over traditional insulin delivery methods. They incorporate minor technological additions, such as memory functions, to provide users with information on their previous dosage and time. These pens are simple to use while providing relief in manual recordkeeping for insulin intake. They aim to help patients adhere to their prescribed insulin regimen, improving glycemic outcomes. Second-generation smart insulin pens are equipped with advanced technology such as bluetooth and USB connectivity, thus enabling them to wirelessly communicate data to other devices for easier management and tracking of insulin usage. Bluetooth-enabled second-generation pens offer seamless connectivity with smartphones and tablets running diabetes management apps. This wireless data transfer from the pen to the app allows personalized dose adjustments, reminders, and a complete log of the patient's insulin administration history. It provides real-time updates and detailed visualizations, increasing patients' confidence in self-managing their condition. USB-connected smart insulin pens add another dimension to data portability and accessibility. They can be connected to devices such as computers and laptops via a USB port for easy data transfer. This provides healthcare practitioners valuable insights into their patients' insulin usage, which can be crucial for improved patient counseling and tailoring the treatment plan for optimizing glucose control.

Usability: Adoption of reusable smart insulin pens due to its cost-efficiency

Prefilled smart insulin pens are ideal for individuals seeking convenience and simplicity. Prefilled smart insulin pens come with a preloaded medication cartridge, eliminating the need to load insulin into the pen before use manually. The user-friendly design reduces the risk of contamination and potential mistakes in dosage calculation. On the other hand, reusable smart insulin pens are suitable for patients who prioritize environmental sustainability and cost-effectiveness above convenience. These pens require users to replace insulin cartridges manually. The prefilled pens offer greater comfort and are less prone to user error, whereas reusable pens are more cost-effective and environmentally friendly in the long run.

Application: Increasing use of smart insulin pens to overcome the burden of Type II diabetes

Type I diabetes, also known as insulin-dependent diabetes, requires stringent blood glucose level monitoring. Efficacy and convenience become crucial factors in choosing an insulin delivery system. That's where the smart insulin pen becomes a game-changer, offering high levels of precision, adherence to insulin regimes, and minimizing the risks of errors and hypoglycemia. Sufferers of Type II diabetes, who typically have insulin resistance, must maintain adequate insulin levels. Due to the progressive nature of Type II diabetes, insulin therapy becomes critical over time. Thus, smart insulin pens are designed to provide a convenient and personalized insulin management solution. Type I diabetes requires more frequent and precise doses. Hence, smart insulin pens for Type I diabetes are focused more on dose recording and timing reminders. For Type II diabetes, due to its progressive nature and varying insulin resistance levels, pens are designed with features like prefilled insulin cartridges and customizable doses.

End-User: Proliferating usage of smart insulin pens in home healthcare settings

Ambulatory surgical centers (ASCs) are healthcare installations that provide same-day surgical care, including diagnostic and preventive procedures. They have shown a growing preference for using smart insulin pens, primarily due to their enhanced accuracy and real-time tracking features that allow better patient monitoring and improved diabetes management. A significant section of the end-user segment, home care settings, is marked by people who prefer to manage their diabetes at home. The ease of use, affordability, and connectivity of smart insulin pens have made them increasingly popular among home users. Hospitals and clinics, as primary care centers, constitute significant end-users of smart insulin pens. These devices are preferred in hospital settings for their precise dosing, user-friendly features, and the ability to wirelessly monitor patient's insulin levels. This can help reduce hospital stay length and improve patient outcomes. ASCs prefer precision and real-time tracking, whereas home users value affordability and ease of use. Hospitals & clinics appreciate the devices' ability to improve patient outcomes through precise dosing and real-time monitoring.

Regional Insights

The Americas have a significant landscape in the smart insulin pen market owing to rising diabetes prevalence, high healthcare expenditure, and the presence of key market players. Countries in the region also contribute to the market growth, incorporating steps to increase awareness about the convenience and effectiveness of smart insulin pens compared to traditional methods. Across EU nations, the rising aging population and increasing awareness of advanced diabetes management systems have escalated the reach of smart insulin pens. Legislation for improved diabetes management and healthcare infrastructure propels investment in the sector. The increasing cases of diabetes in the Middle East and Africa have spiked interest in smart insulin pens. In terms of regulation, governments have initiated policies to deliver innovative healthcare solutions to their citizens, potentially accelerating growth in these emerging markets. The APAC region is expected to be the growing market for smart insulin pens due to their teeming populations, which are large pools of potential customers grappling with diabetes. Governments are becoming increasingly sensitive to the need for modern diabetes treatment methods, driving the demand for smart insulin pens.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Smart Insulin Pen Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smart Insulin Pen Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Smart Insulin Pen Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Berlin-Chemie AG, Bigfoot Biomedical Inc., BIOCORP Production, Dexcom, Inc., Diamesco Co., Ltd., Eli Lilly and Company, Emperra GmbH, F. Hoffmann-La Roche AG, HTL-Strefa, Inc., Insulet Corporation, IQVIA Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk A/S, Owen Mumford Ltd., pendiq GmbH, Sanofi S.A., Tandem Diabetes Care Inc., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Smart Insulin Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- First Generation Pens
- Second Generation Pens
  - Bluetooth-Enabled
  - USB Connected
Usability
- Prefilled
- Reusable

Application
- Type I Diabetes
- Type II Diabetes

End-User
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Smart Insulin Pen Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smart Insulin Pen Market?

3. What are the technology trends and regulatory frameworks in the Smart Insulin Pen Market?

4. What is the market share of the leading vendors in the Smart Insulin Pen Market?

5. Which modes and strategic moves are suitable for entering the Smart Insulin Pen Market?

Product Code: MRR-0375F3EA9C4E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in diabetes patients worldwide
  - 5.1.1.2. Emphasis on calculating personalized doses and glucose monitoring
  - 5.1.1.3. Rising acceptance of connected devices and apps for diabetes care in home healthcare settings
- 5.1.2. Restraints
  - 5.1.2.1. High costs of smart insulin pens
- 5.1.3. Opportunities
  - 5.1.3.1. Improvements in product offerings with innovative developments
  - 5.1.3.2. Supportive government initiatives and investments for home healthcare solutions
- 5.1.4. Challenges
  - 5.1.4.1. Limited awareness and technical issues associated with handling smart insulin pens
5.2. Market Segmentation Analysis
- 5.2.1. Type: Second-generation pens offer higher control to diabetes management
- 5.2.2. Usability: Adoption of reusable smart insulin pens due to its cost-efficiency
- 5.2.3. Application: Increasing use of smart insulin pens to overcome the burden of Type II diabetes
- 5.2.4. End-User: Proliferating usage of smart insulin pens in home healthcare settings
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Smart Insulin Pen Market, by Type

6.1. Introduction
6.2. First Generation Pens
6.3. Second Generation Pens

7. Smart Insulin Pen Market, by Usability

7.1. Introduction
7.2. Prefilled
7.3. Reusable

8. Smart Insulin Pen Market, by Application

8.1. Introduction
8.2. Type I Diabetes
8.3. Type II Diabetes

9. Smart Insulin Pen Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Home Care Settings
9.4. Hospitals & Clinics

10. Americas Smart Insulin Pen Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Smart Insulin Pen Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Smart Insulin Pen Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Abbott to Buy Smart Insulin Pen Cap Maker Bigfoot
- 13.3.2. FDA Clears Mallya Smart Insulin Pen Device from Biocorp
- 13.3.3. BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya Smart Sensor
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio